| 000 | 03686cam a22004814i 4500 | ||
|---|---|---|---|
| 999 |
_c12776 _d12776 |
||
| 001 | 15205792 | ||
| 005 | 20210303124343.0 | ||
| 008 | 080303s2009 njua b 001 0 eng | ||
| 010 | _a 2008009573 | ||
| 016 | 7 |
_a101467523 _2DNLM |
|
| 020 | _a9780470056097 (cloth) | ||
| 020 | _a0470056096 (cloth) | ||
| 035 | _a(OCoLC)213008102 | ||
| 040 |
_aDNLM/DLC _cDLC _dNLM _dBAKER _dBTCTA _dYDXCP _dC#P _dIXA _dDLC _erda |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRM301.8 _b.F67 2009 |
| 082 | 0 | 0 |
_a615.1 _222 _bF. |
| 245 | 0 | 0 |
_aFormulation and analytical development for low-dose oral drug products / _cedited by Jack Zheng, pharmaceutical Sciences R&D, Lilly Research Labs, Eli Lilly and company |
| 264 | 1 |
_aHoboken, N.J. : _bJohn Wiley & Sons, _c[2009] |
|
| 264 | 4 | _c©2009 | |
| 300 |
_axxiii, 461 pages : _billustartions ; _c25 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aAn overview / Jack Y. Zheng -- Challenges and strategies in formulation development of oral solid low-dose drug products / Jack Y. Zheng -- Particle size of drug substance and product content uniformity: theoretical considerations / Kevin C. Johnson -- Development of low-dose formulations using fluidized bed granulation / J. Joe Zhou, and Ralph Lipp -- Development of low-dose solid oral formulations using wet granulation / Ahmad Almaya -- Challenges in development and scale-up of low dose drug products by dry granulation: a case study / Mary T. Am Ende ... [et al.] -- Development of low-dose solid oral tablets using direct compression / Jack Y. Zheng and Robert L. Ternik -- Reduction of particle size of drug substance for low-dose drug products / Christopher L. Burcham ... [et al.] -- Function, quality, and regulations of pharmaceutical excipients for oral solid dosage forms / Jack Y. Zheng -- | |
| 505 | 0 | _aAnalytical method development: challenges and solutions for low-dose oral dosage forms / Beverly Nickerson ... [et al.] -- In vitro dissolution testing and method development / Vivian A. Gray, Jack Y. Zheng, and Norman N. Sesi -- Analysis of physical transformation of API during manufacture and storage / Gregory A. Stephenson -- Physical characterization tests for drug substances used in low-dose formulations / Ronald G. Lacocca -- An excipient library approach to analytical development for low-dose, solid oral dosage form drug products / Qing Chang ... [et al.] -- Cleaning verification for highly potent compounds / Brian W. Pack -- Containment challenges and strategies for potent compounds in the pharmaceutical industry / Victoria Cathcart, Sarah Jones, Beverly Nickerson -- Sample handling and containment in analytical testing laboratories / David Pattavina, Nancy Sage, Beverly Nickerson -- Regulatory considerations in the development of low-dose solid oral drug products / Ravi S. Harapanhalli. | |
| 650 | 0 |
_aDrugs _xDose-response relationship. |
|
| 650 | 0 |
_aDrugs _xDosage. |
|
| 650 | 0 | _aOral medication. | |
| 650 | 0 | _aDrug development. | |
| 650 | 1 | 2 |
_aChemistry, Pharmaceutical _xmethods. |
| 650 | 2 | 2 | _aAdministration, Oral. |
| 650 | 2 | 2 |
_aDrug Evaluation, Preclinical _xmethods. |
| 650 | 2 | 2 | _aDrug Industry. |
| 700 | 1 |
_aZheng, Jack. _eeditor. |
|
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0827/2008009573-d.html |
| 856 | 4 | 1 |
_3Table of contents only _uhttp://www.loc.gov/catdir/enhancements/fy0827/2008009573-t.html |
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||